Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
Market Analysis and Insights: Global Hospital Injectable Drugs Market
Prior to COVID-19, the market for Hospital Injectable Drugs was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Hospital Injectable Drugs is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Hospital Injectable Drugs market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hospital Injectable Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Hospital Injectable Drugs industry.
Global Hospital Injectable Drugs Scope and Segment
Hospital Injectable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
AstraZeneca
Gilead
Sciences
Merck & Co.
Novartis AG
Johnson & Johnson
Novo Nordisk A/S
Hospital Injectable Drugs Breakdown Data by Type
Cardiology& Metabolicdisorders
Neurology
Oncology
Autoimmune
Gastroenterology
Hematology
Pain
Infectiousdiseases
Others
Hospital Injectable Drugs Breakdown Data by Application
HospitalPharmacy
RetailPharmacy
E-commerce
Regional and Country-level Analysis
The Hospital Injectable Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hospital Injectable Drugs market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Hospital Injectable Drugs Market Share Analysis
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
Market Analysis and Insights: Global Hospital Injectable Drugs Market
Prior to COVID-19, the market for Hospital Injectable Drugs was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Hospital Injectable Drugs is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Hospital Injectable Drugs market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hospital Injectable Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Hospital Injectable Drugs industry.
Global Hospital Injectable Drugs Scope and Segment
Hospital Injectable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
AstraZeneca
Gilead
Sciences
Merck & Co.
Novartis AG
Johnson & Johnson
Novo Nordisk A/S
Hospital Injectable Drugs Breakdown Data by Type
Cardiology& Metabolicdisorders
Neurology
Oncology
Autoimmune
Gastroenterology
Hematology
Pain
Infectiousdiseases
Others
Hospital Injectable Drugs Breakdown Data by Application
HospitalPharmacy
RetailPharmacy
E-commerce
Regional and Country-level Analysis
The Hospital Injectable Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hospital Injectable Drugs market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Hospital Injectable Drugs Market Share Analysis
1 Study Coverage
1.1 Hospital Injectable Drugs Product Introduction
1.2 Market Segments
1.3 Key Hospital Injectable Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type
1.4.2 Cardiology& Metabolicdisorders
1.4.3 Neurology
1.4.4 Oncology
1.4.5 Autoimmune
1.4.6 Gastroenterology
1.4.7 Hematology
1.4.8 Pain
1.4.9 Infectiousdiseases
1.4.10 Others
1.5 Market by Application
1.5.1 Global Hospital Injectable Drugs Market Size Growth Rate by Application
1.5.2 HospitalPharmacy
1.5.3 RetailPharmacy
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hospital Injectable Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hospital Injectable Drugs Revenue 2015-2026
2.1.2 Global Hospital Injectable Drugs Sales 2015-2026
2.2 Global Hospital Injectable Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hospital Injectable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hospital Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hospital Injectable Drugs Competitor Landscape by Players
3.1 Hospital Injectable Drugs Sales by Manufacturers
3.1.1 Hospital Injectable Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hospital Injectable Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hospital Injectable Drugs Revenue by Manufacturers
3.2.1 Hospital Injectable Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hospital Injectable Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2019
3.2.5 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hospital Injectable Drugs Price by Manufacturers
3.4 Hospital Injectable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hospital Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hospital Injectable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hospital Injectable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Injectable Drugs Market Size by Type (2015-2020)
4.1.1 Global Hospital Injectable Drugs Sales by Type (2015-2020)
4.1.2 Global Hospital Injectable Drugs Revenue by Type (2015-2020)
4.1.3 Hospital Injectable Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hospital Injectable Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hospital Injectable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hospital Injectable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hospital Injectable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hospital Injectable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hospital Injectable Drugs Market Size by Application (2015-2020)
5.1.1 Global Hospital Injectable Drugs Sales by Application (2015-2020)
5.1.2 Global Hospital Injectable Drugs Revenue by Application (2015-2020)
5.1.3 Hospital Injectable Drugs Price by Application (2015-2020)
5.2 Hospital Injectable Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hospital Injectable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hospital Injectable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hospital Injectable Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hospital Injectable Drugs by Country
6.1.1 North America Hospital Injectable Drugs Sales by Country
6.1.2 North America Hospital Injectable Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hospital Injectable Drugs Market Facts & Figures by Type
6.3 North America Hospital Injectable Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Hospital Injectable Drugs by Country
7.1.1 Europe Hospital Injectable Drugs Sales by Country
7.1.2 Europe Hospital Injectable Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hospital Injectable Drugs Market Facts & Figures by Type
7.3 Europe Hospital Injectable Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hospital Injectable Drugs by Region
8.1.1 Asia Pacific Hospital Injectable Drugs Sales by Region
8.1.2 Asia Pacific Hospital Injectable Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hospital Injectable Drugs by Country
9.1.1 Latin America Hospital Injectable Drugs Sales by Country
9.1.2 Latin America Hospital Injectable Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hospital Injectable Drugs Market Facts & Figures by Type
9.3 Central & South America Hospital Injectable Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hospital Injectable Drugs by Country
10.1.1 Middle East and Africa Hospital Injectable Drugs Sales by Country
10.1.2 Middle East and Africa Hospital Injectable Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Hospital Injectable Drugs Products Offered
11.2.5 Sanofi Related Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Description and Business Overview
11.3.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Inc. Hospital Injectable Drugs Products Offered
11.3.5 Pfizer Inc. Related Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Corporation Information
11.4.2 GlaxoSmithKline plc Description and Business Overview
11.4.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline plc Hospital Injectable Drugs Products Offered
11.4.5 GlaxoSmithKline plc Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Hospital Injectable Drugs Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Gilead
11.6.1 Gilead Corporation Information
11.6.2 Gilead Description and Business Overview
11.6.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gilead Hospital Injectable Drugs Products Offered
11.6.5 Gilead Related Developments
11.7 Sciences
11.7.1 Sciences Corporation Information
11.7.2 Sciences Description and Business Overview
11.7.3 Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sciences Hospital Injectable Drugs Products Offered
11.7.5 Sciences Related Developments
11.8 Merck & Co.
11.8.1 Merck & Co. Corporation Information
11.8.2 Merck & Co. Description and Business Overview
11.8.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co. Hospital Injectable Drugs Products Offered
11.8.5 Merck & Co. Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Hospital Injectable Drugs Products Offered
11.9.5 Novartis AG Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Hospital Injectable Drugs Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hospital Injectable Drugs Market Estimates and Projections by Region
12.1.1 Global Hospital Injectable Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hospital Injectable Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hospital Injectable Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hospital Injectable Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hospital Injectable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 Hospital Injectable Drugs Product Introduction
1.2 Market Segments
1.3 Key Hospital Injectable Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type
1.4.2 Cardiology& Metabolicdisorders
1.4.3 Neurology
1.4.4 Oncology
1.4.5 Autoimmune
1.4.6 Gastroenterology
1.4.7 Hematology
1.4.8 Pain
1.4.9 Infectiousdiseases
1.4.10 Others
1.5 Market by Application
1.5.1 Global Hospital Injectable Drugs Market Size Growth Rate by Application
1.5.2 HospitalPharmacy
1.5.3 RetailPharmacy
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hospital Injectable Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hospital Injectable Drugs Revenue 2015-2026
2.1.2 Global Hospital Injectable Drugs Sales 2015-2026
2.2 Global Hospital Injectable Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hospital Injectable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hospital Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hospital Injectable Drugs Competitor Landscape by Players
3.1 Hospital Injectable Drugs Sales by Manufacturers
3.1.1 Hospital Injectable Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hospital Injectable Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hospital Injectable Drugs Revenue by Manufacturers
3.2.1 Hospital Injectable Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hospital Injectable Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2019
3.2.5 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hospital Injectable Drugs Price by Manufacturers
3.4 Hospital Injectable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hospital Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hospital Injectable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hospital Injectable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Injectable Drugs Market Size by Type (2015-2020)
4.1.1 Global Hospital Injectable Drugs Sales by Type (2015-2020)
4.1.2 Global Hospital Injectable Drugs Revenue by Type (2015-2020)
4.1.3 Hospital Injectable Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hospital Injectable Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hospital Injectable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hospital Injectable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hospital Injectable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hospital Injectable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hospital Injectable Drugs Market Size by Application (2015-2020)
5.1.1 Global Hospital Injectable Drugs Sales by Application (2015-2020)
5.1.2 Global Hospital Injectable Drugs Revenue by Application (2015-2020)
5.1.3 Hospital Injectable Drugs Price by Application (2015-2020)
5.2 Hospital Injectable Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hospital Injectable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hospital Injectable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hospital Injectable Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hospital Injectable Drugs by Country
6.1.1 North America Hospital Injectable Drugs Sales by Country
6.1.2 North America Hospital Injectable Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hospital Injectable Drugs Market Facts & Figures by Type
6.3 North America Hospital Injectable Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Hospital Injectable Drugs by Country
7.1.1 Europe Hospital Injectable Drugs Sales by Country
7.1.2 Europe Hospital Injectable Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hospital Injectable Drugs Market Facts & Figures by Type
7.3 Europe Hospital Injectable Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hospital Injectable Drugs by Region
8.1.1 Asia Pacific Hospital Injectable Drugs Sales by Region
8.1.2 Asia Pacific Hospital Injectable Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hospital Injectable Drugs by Country
9.1.1 Latin America Hospital Injectable Drugs Sales by Country
9.1.2 Latin America Hospital Injectable Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hospital Injectable Drugs Market Facts & Figures by Type
9.3 Central & South America Hospital Injectable Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hospital Injectable Drugs by Country
10.1.1 Middle East and Africa Hospital Injectable Drugs Sales by Country
10.1.2 Middle East and Africa Hospital Injectable Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Hospital Injectable Drugs Products Offered
11.2.5 Sanofi Related Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Description and Business Overview
11.3.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Inc. Hospital Injectable Drugs Products Offered
11.3.5 Pfizer Inc. Related Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Corporation Information
11.4.2 GlaxoSmithKline plc Description and Business Overview
11.4.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline plc Hospital Injectable Drugs Products Offered
11.4.5 GlaxoSmithKline plc Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Hospital Injectable Drugs Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Gilead
11.6.1 Gilead Corporation Information
11.6.2 Gilead Description and Business Overview
11.6.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gilead Hospital Injectable Drugs Products Offered
11.6.5 Gilead Related Developments
11.7 Sciences
11.7.1 Sciences Corporation Information
11.7.2 Sciences Description and Business Overview
11.7.3 Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sciences Hospital Injectable Drugs Products Offered
11.7.5 Sciences Related Developments
11.8 Merck & Co.
11.8.1 Merck & Co. Corporation Information
11.8.2 Merck & Co. Description and Business Overview
11.8.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co. Hospital Injectable Drugs Products Offered
11.8.5 Merck & Co. Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Hospital Injectable Drugs Products Offered
11.9.5 Novartis AG Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Hospital Injectable Drugs Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hospital Injectable Drugs Market Estimates and Projections by Region
12.1.1 Global Hospital Injectable Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hospital Injectable Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hospital Injectable Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hospital Injectable Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hospital Injectable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
